BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28148271)

  • 1. Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis.
    He J; Li Y; An J; Hu L; Zhang J
    World J Surg Oncol; 2017 Feb; 15(1):36. PubMed ID: 28148271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
    Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
    World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.
    Torok JA; Gu L; Tandberg DJ; Wang X; Harpole DH; Kelsey CR; Salama JK
    Clin Lung Cancer; 2017 Jan; 18(1):e57-e70. PubMed ID: 27477488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
    J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
    J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.
    Pepek JM; Chino JP; Marks LB; D'amico TA; Yoo DS; Onaitis MW; Ready NE; Hubbs JL; Boyd J; Kelsey CR
    J Thorac Oncol; 2011 Apr; 6(4):757-61. PubMed ID: 21325975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
    Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer.
    Maeda R; Yoshida J; Ishii G; Aokage K; Hishida T; Nishimura M; Nishiwaki Y; Nagai K
    J Thorac Oncol; 2010 Aug; 5(8):1246-50. PubMed ID: 20559152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
    Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
    J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors.
    Kelsey CR; Fornili M; Ambrogi F; Higgins K; Boyd JA; Biganzoli E; Demicheli R
    Clin Lung Cancer; 2013 Jul; 14(4):425-32. PubMed ID: 23499299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients.
    Matsumura Y; Hishida T; Shimada Y; Ishii G; Aokage K; Yoshida J; Nagai K
    J Thorac Oncol; 2014 Mar; 9(3):337-44. PubMed ID: 24496002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
    Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver.
    Ishige F; Takayama W; Chiba S; Hoshino I; Arimitsu H; Yanagibashi H; Iwatate Y
    Int J Clin Oncol; 2018 Aug; 23(4):647-651. PubMed ID: 29511939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer.
    Verhagen AF; Bulten J; Shirango H; Thunnissen FB; van der Drift MA; van der Bruggen W; Tjan-Heijnen VC; van Swieten HA
    J Thorac Oncol; 2010 Aug; 5(8):1201-5. PubMed ID: 20588201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.